Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

131 ARTÍCULOS , VIENDO DEL 46 AL 60

[Diagnosis of Alzheimer's disease]

Derouesné C.

Psychol Neuropsychiatr Vieil. 2010 Mar;8(1):5-6. doi: 10.1684/pnv.2010.0202.

[What use of biological markers for the diagnosis of Alzheimer's disease and associated disorders?]

Krolak-Salmon P.

Psychol Neuropsychiatr Vieil. 2010 Mar;8(1):25-31. doi: 10.1684/pnv.2009.0189.

[Importance of molecular diagnostics in Alzheimer dementia. A case report]

Honneth J, Nehen HG, Haseke J.

Z Gerontol Geriatr. 2010 Jun;43(3):177-9. doi: 10.1007/s00391-010-0101-1. Epub 2010 Apr 1.

Cerebrospinal fluid biomarkers of Alzheimer's disease

Fagan AM, Holtzman DM.

Biomark Med. 2010 Feb;4(1):51-63. doi: 10.2217/BMM.09.83.

Aging and lateralization of the rat brain on a biochemical level

Kristofiková Z, Rícný J, Ort M, Rípová D.

Neurochem Res. 2010 Aug;35(8):1138-46. doi: 10.1007/s11064-010-0165-8. Epub 2010 Apr 6.

Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease

Rabinovici GD, Roberson ED.

Ann Neurol. 2010 Mar;67(3):283-5. doi: 10.1002/ana.22020.

Biomarkers of oxidative damage and inflammation in Alzheimer's disease

Galasko D, Montine TJ.

Biomark Med. 2010 Feb;4(1):27-36. doi: 10.2217/bmm.09.89.

Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible

Reiman EM, Langbaum JB, Tariot PN.

Biomark Med. 2010 Feb;4(1):3-14. doi: 10.2217/bmm.09.91.

Biomarkers in Alzheimer's disease: past, present and future

Gustaw-Rothenberg K, Lerner A, Bonda DJ, Lee HG, Zhu X, Perry G, Smith MA.

Biomark Med. 2010 Feb;4(1):15-26. doi: 10.2217/bmm.09.86.

Role of progranulin as a biomarker for Alzheimer's disease

Sleegers K, Brouwers N, Van Broeckhoven C.

Biomark Med. 2010 Feb;4(1):37-50. doi: 10.2217/bmm.09.82.

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

Thambisetty M, Lovestone S.

Biomark Med. 2010 Feb;4(1):65-79. doi: 10.2217/bmm.09.84.

Role of biochemical Alzheimer's disease biomarkers as end points in clinical trials

Siemers E, DeMattos RB, May PC, Dean RA.

Biomark Med. 2010 Feb;4(1):81-9. doi: 10.2217/bmm.09.85.

Biochemical markers in Alzheimer's disease clinical trials

Zetterberg H, Mattsson N, Shaw LM, Blennow K.

Biomark Med. 2010 Feb;4(1):91-8. doi: 10.2217/bmm.09.80.

Correlating familial Alzheimer's disease gene mutations with clinical phenotype

Ryan NS, Rossor MN.

Biomark Med. 2010 Feb;4(1):99-112. doi: 10.2217/bmm.09.92.

Biomarkers in translational research of Alzheimer's disease

Tarawneh R, Holtzman DM.

Neuropharmacology. 2010 Sep-Oct;59(4-5):310-22. doi: 10.1016/j.neuropharm.2010.04.006. Epub 2010 Apr 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias